Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease

New England Journal of Medicine

Volumn 334, Issue 10, 1996, Pages 619-623

  Schreiber, Stefan ^a,b,d   Howaldt, Stefanie ^a   Schnoor, Mareille ^a   Nikolaus, Susanna ^b   Bauditz, Jurgen ^b   Gasché, Christoph ^c   Lochs, Herbert ^b   Raedler, Andreas ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c UNIVERSITY OF VIENNA   (Austria)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID DERIVATIVE; CORTICOSTEROID; ERYTHROPOIETIN; FERROSANOL DUODENAL; HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT FAILURE; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; ANEMIA; COLITIS, ULCERATIVE; CROHN DISEASE; DOUBLE-BLIND METHOD; DRUG RESISTANCE; ERYTHROPOIETIN; FEMALE; HEMATOCRIT; HUMANS; INTERLEUKIN-1; IRON; LINEAR MODELS; MALE; MIDDLE AGED; MONOCYTES; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 0029931837     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199603073341002     Document Type: Article

References (24)

1. Johannsen H, Jelkmann W, Wiedemann G, Otte M, Wagner T. Erythropoietin/haemoglobulin relationship in leukaemia and ulcerative colitis. Eur J Haematol 1989;43:201-6.
2. Horina JH, Petritsch W, Schmid CR, et al. Treatment of anemia in inflammatory bowel disease with recombinant human erythropoietin: results in three patients. Gastroenterology 1993;104:1828-31.
3. Eschbach JW, Adamson JW. Guidelines for recombinant human erythropoietin therapy Am J Kidney Dis 1989;14:Suppl 1:2-8.
4. Mahida YR, Wu K, Jewell DP. Enhanced production of interleukin 1-β by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut 1989;30 835-8.
5. Ligumsky M, Simon PL, Karmeli F, Rachmilewitz D. Role of interleukin 1 in inflammatory bowel disease - enhanced production during active disease. Gut 1990;31:686-9.
6. MacDonald TT, Hutchings P, Choy MY, Murch S, Cooke A. Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol 1990; 81:301-5.
7. Reinecker H-C, Steffen M, Witthoeft T, et al. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993;94:174-81.
8. Means RT Jr, Krantz SB. Inhibition of human erythroid colony-forming units by gamma interferon can be corrected by recombinant human erythropoietin. Blood 1991;78:2564-7.
9. Faquin WC, Schneider TJ, Goldberg MA. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 1992;79: 1987-94.
10. Smith MA, Knight SM, Maddison PJ, Smith JG. Anaemia of chronic disease in rheumatoid arthritis: effect of the blunted response to erythropoietin and of interleukin 1 production by marrow macrophages. Ann Rheum Dis 1992; 51:753-7.
11. Henry DH Changing patterns of care in the management of anemia. Semin Oncol 1992;19:Suppl 8:3-7.
12. Best WR, Becktel JM, Singleton JW, Kern F Jr Development of a Crohn's disease activity index: National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439-44.
13. Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI). Gastroenterology 1979;77:843-6.
14. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 1989;298:82-6.
15. Schlageter MH, Toubert ME, Podgorniak MP, Najean Y Radioimmunoassay of erythropoietin: analytical performance and clinical use in hematology. Clin Chem 1990;36:1731-5.
16. Cotes PM. Immunoreactive erythropoietin in serum. I Evidence for the validity of the assay method and the physiological relevance of estimates. Br J Haematol 1982;50 427-38.
17. Boyum A. Isolation of mononuclear cells and granulocytes from human blood: isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 1968;97:77-89.
18. Schreiber S, Heinig T, Panzer U, et al Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease. Gastroenterology 1995;108:21-33.
19. Shapiro SS, Wilk MB, Chen HJ. Comparative study of various tests of normality. J Am Stat Assoc 1968;63:1343-72.
20. Sachs L. Angewandte Statistik. 7th ed Heidelberg, Germany: Springer-Verlag. 1992.
21. Cazzola M, Bequin Y. New tools for clinical evaluation of erythron function in man Br J Haematol 1992;80.278-84.
22. Erslev AJ, Caro J, Miller O, Silver R. Plasma erythropoietin in health and disease. Ann Clin Lab Sci 1980,10:250-7
23. Fuchs D, Hausen A, Reibnegger G, et al. Immune activation and the anaemia associated with chronic inflammatory disorders. Eur J Haematol 1991;46:65-70.
24. Macdougall IC, Roberts DE, Neubert P, Dharmasena AD, Coles GA, Williams JD Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis Lancet 1989;1:425-7